Certified by Founder Lodge
Coave Therapeutics
France - PARIS
START UP
1 Disclosed Funding Rounds $32,000,000
0 Participating Investments
-
Founded date
2014
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases.
We are pushing the
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 09 ,2025 | Series A | $32,000,000 |
Bpifrance
Omnes
Novo Holdings
UI Investissement
Turenne Groupe
Kurma Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
RLTYco | $20,000,000 | (Jan 10, 2025)
Prudentia Sciences | $7,000,000 | (Jan 10, 2025)
RyboDyn Inc. | $4,000,000 | (Jan 10, 2025)
Abstract(US) | $4,800,000 | (Jan 10, 2025)
Air | $35,000,000 | (Jan 10, 2025)
